Sleeve Gastrectomy in Different Age Groups: a Comparative Study of 5-Year Outcomes
Background Laparoscopic sleeve gastrectomy (LSG) has been used more frequently over the past 10 years. As the population ages, a larger number of older people will suffer from weight-related comorbidities, resulting in bariatric surgery becoming a dominant solution for improving health and quality o...
Saved in:
Published in | Obesity surgery Vol. 26; no. 2; pp. 289 - 295 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.02.2016
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Laparoscopic sleeve gastrectomy (LSG) has been used more frequently over the past 10 years. As the population ages, a larger number of older people will suffer from weight-related comorbidities, resulting in bariatric surgery becoming a dominant solution for improving health and quality of life. We assessed the long-term outcomes of LSG in elderly patients.
Methods
We conducted a retrospective chart review of patients who underwent LSG between January 2007 and August 2009. We subdivided 123 patients into <35 (
n
= 43), 35–55 (
n
= 59), and >55 (
n
= 21) age groups.
Results
The respective mean excess body mass index loss and excess weight loss were 42.5 % ± 3.1 % and 41.3 % ± 12.3 % for the <35 age group, 48.7 % ± 4.1 % and 45.6 % ± 10.6 % for the 35–55 age group, and 53.6 % ± 4.6 % and 52.1 % ± 11.1 % for the >55 age group. The follow-up compliance rates at the 5-year visit were 23.85, 31.11, and 47.61 % for the <35, 35–55, and >55 age groups, respectively. The corresponding Bariatric Analysis and Reporting Outcome System scores were 3.7 ± 1.1, 4.0 ± 0.7, and 5.3 ± 1.3. The comorbidities of all the patients improved significantly, with a non-significant distribution between the three groups for each comorbidity.
Conclusions
LSG is a useful tool for people who want to modify their eating habits and lose weight healthily. This study suggests that long-term weight loss, improvements in comorbidity, and compliance to follow-up are significant for patients >55 years old. |
---|---|
ISSN: | 0960-8923 1708-0428 |
DOI: | 10.1007/s11695-015-1735-2 |